FIELD: biotechnology; medicine.
SUBSTANCE: disclosed is a method for predicting the risk of developing duodenal ulcer based on molecular genetic testing, involving sampling peripheral venous blood, recovering DNA from peripheral venous blood leukocytes and analysing polymorphic loci rs2294008 of gene PSCA and rs2519093 of gene ABO. Detection during analysis of combination of polymorphic loci rs2294008 (PSCA) CC x rs2519093 (ABO) CC predicts a high risk of developing duodenal ulcer in individuals of Russian nationality born in the Central Black Earth Region of Russia and living in the Belgorod region.
EFFECT: invention enables to form risk groups for developing duodenal ulcer in individuals of Russian nationality at the preclinical level and to implement the necessary therapeutic and preventive measures in these groups.
1 cl, 2 dwg
Authors
Dates
2024-04-01—Published
2023-10-20—Filed